This inventor holds 1 USPTO granted patent. Top assignees: 2692372 Ontario, Inc., Dunad Therapeutics Ltd.. Active years: 2026.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2026
Title: Innovations of Aaron D Cabral
Introduction
Aaron D Cabral is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzenesulfonamide derivatives. His research focuses on the disruption of proteins and polypeptides, which are crucial in the treatment of various diseases.
Latest Patents
Aaron D Cabral holds a patent for "Benzenesulfonamide derivatives and uses thereof." This patent includes compounds that have the potential to disrupt protein and polypeptide functions, offering new avenues for treating diseases linked to these biological molecules. The compounds he developed feature fluorinated benzene sulfonamide structures, which enhance their efficacy in pharmaceutical applications.
Career Highlights
Throughout his career, Cabral has worked with several companies, including 2692372 Ontario, Inc. and Dunad Therapeutics Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical science.
Collaborations
Aaron D Cabral has collaborated with notable professionals in his field, including David Armstrong and Geordon A Frere. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of new technologies.
Conclusion
Aaron D Cabral's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing new treatments for diseases. His ongoing efforts continue to inspire advancements in medical science.